Company Filing History:
Years Active: 2021-2024
Title: Innovations in Depression Treatment: The Contributions of Patrick Marshalek
Introduction
Patrick Marshalek, a notable inventor based in Morgantown, West Virginia, has made significant strides in the field of medical innovation. With a total of three patents to his name, Marshalek's work primarily focuses on developing effective treatments for depression, particularly in patients who are resistant to conventional therapies.
Latest Patents
One of Marshalek’s most recent inventions includes patents for ketamine or dextromethorphan formulations and methods of use. This invention outlines a novel method of treating depression in treatment-resistant patients. The method involves administering an effective amount of a pharmaceutically acceptable composition containing ketamine or dextromethorphan to a mucosal membrane of the patient. This approach allows for mucosal absorption of the medication, bypassing the digestive tract and ensuring a rapid acting antidepressant effect. The method can include administration to various mucosal sites, such as the respiratory tract, genitourinary tract, oral tract, or rectal tract. Furthermore, the patent discusses the identification of biomarkers that can help in diagnosing depressive diseases, which enhances the precision of treatment for affected individuals.
Career Highlights
Patrick Marshalek currently works at West Virginia University, where he continues to innovate in the field of mental health treatments. His expertise and dedication to his research serve to advance the understanding and management of depression, thereby improving the quality of life for many patients.
Collaborations
Throughout his career, Marshalek has collaborated with notable coworkers, including Scott Pollard and Rae Matsumoto. These partnerships have been instrumental in the development and refinement of his innovative approaches to treating depression, fostering a team-oriented environment that enhances productivity and creativity in research.
Conclusion
Patrick Marshalek’s contributions to the field of medical innovation reflect a dedicated pursuit of solutions for challenging health issues, such as treatment-resistant depression. His patented methods utilizing ketamine and dextromethorphan represent noteworthy advancements, potentially transforming the landscape of antidepressant therapies. As research continues to evolve, Marshalek's work may pave the way for even more effective treatments, ultimately benefiting countless individuals struggling with depression.